60. MANAGEMENT AND TREATMENT OF SOLITARY PULMONARY NODULE DETECTED BY LOW-DOSE COMPUTED TOMOGRAPHY: UPDATED GUIDELINES AND A CLINICAL CASE

Tran Huu Phuoc1, Tieu Chi Duc1
1 Gia Dinh People's Hospital

Main Article Content

Abstract

Overview: A solitary pulmonary nodule (SPN) is a lesion measuring less than 3 cm, typically discovered incidentally through diagnostic imaging techniques. In recent years, low-dose computed tomography (LDCT) has become a popular screening method, particularly in lung cancer screening programs for high-risk groups. LDCT provides the capability for early detection of small lesions and significantly reduces radiation exposure compared to conventional CT, thereby mitigating negative impacts associated with radiation exposure. However, the management of solitary pulmonary nodules still faces many challenges, particularly in distinguishing between benign and malignant nodules. The management process is based on clinical evaluation, risk factors, and imaging characteristics of the nodule on LDCT.


Clinical Case: A 70-year-old male patient with a history of smoking was found to have a solitary pulmonary nodule measuring 10 mm on LDCT during a lung cancer screening program. The nodule exhibited irregular margins and was asymptomatic. Based on risk factors and imaging characteristics, the patient was referred for a PET-CT scan to further assess malignancy. The PET-CT results indicated high metabolic activity in the nodule, suggesting a potential malignancy. Due to the location of the nodule, a biopsy under CT guidance was not feasible. The patient underwent thoracoscopic surgery for a cold biopsy, and the results confirmed early-stage lung cancer. Subsequently, the patient underwent a lower left lobectomy. The patient recovered well and was placed under regular follow-up.


Conclusion: Low-dose computed tomography plays a crucial role in the early detection of solitary pulmonary nodules, thereby enhancing the efficacy of lung cancer screening and treatment. The management and treatment of pulmonary nodules require a combination of clinical risk factors, imaging studies, and invasive diagnostic methods when necessary. The monitoring and treatment process should be individualized based on each specific case to optimize treatment outcomes, ultimately improving patient survival rates.

Article Details

References

[1] National Lung Screening Trial Research T, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. Aug 4 2011;365(5):395-409. doi:10.1056/NEJMoa1102873
[2] de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. Feb 6 2020;382(6):503-513. doi:10.1056/NEJMoa1911793
[3] MacMahon H, Naidich DP, Goo JM, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images:
From the Fleischner Society 2017. Radiology. Jul 2017;284(1):228-243. doi:10.1148/radiol.2017161659
[4] Hadique S, Jain P, Hadi Y, Baig A, Parker JE. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening. BMC Medical Imaging. 2020;20(1)doi:10.1186/s12880-020-00469-0
[5] Elkhayat H, Rivas DG. Long-term survival following thoracoscopic versus open lobectomy for stage I non-small cell lung cancer. Annals of
Translational Medicine. 2019;7(S3):S147-S147. doi:10.21037/atm.2019.06.24